Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Valuation
Financial Asset and Business Valuation
Financial Asset and Business Valuation
NERA economists help clients establish a fair and accurate valuation of a business and/or IPO. Business valuation depends on financial forecasting and analysis -- but that is only the beginning. To make sound forecasts, it is important to understand the dynamics of the marketplace. This is the hallmark of NERA's approach -- one that has been successfully used by business owners and attorneys in litigation, and investment bankers/venture capitalists interested in acquiring a real measure of business value.
| Name | Title | Location | Phone | |
|---|---|---|---|---|
| Dr. Sumanth Addanki | Managing Director | White Plains, NY | +1 914 448 4060 | sumanth.addanki@nera.com |
| Oscar Arnedillo | Managing Director | Madrid | +34 91 521 0020 | oscar.arnedillo@nera.com |
| Dr. Fabrizio Hernández | Managing Director |
Madrid
Milan |
+34 91 521 00 20
+39 02 30577800 |
fabrizio.hernandez@nera.com |
| Dr. Vinita Juneja |
Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice |
New York City
London Toronto |
+1 212 345 3148
+44 20 7659 8618 +1 416 868 7314 |
vinita.juneja@nera.com |
| Dr. Jeff D. Makholm | Managing Director | Boston | +1 617 927 4540 | jeff.makholm@nera.com |
| Dr. Denise Neumann Martin | Managing Director | Miami | +1 305 808 7880 | denise.martin@nera.com |
| Dr. Faten Sabry |
Managing Director
Chair of NERA's Global Securities and Finance Practice Bankruptcy Practice Chair |
New York City
London |
+1 212 345 3285
+44 20 7659 8618 |
faten.sabry@nera.com |
| Kurt G. Strunk | Managing Director | New York City | +1 212 345 5035 | kurt.strunk@nera.com |
| Bradley A. Heys | Director |
Toronto
New York City |
+1 416 868 7312
+1 212 345 2691 |
brad.heys@nera.com |
| Dr. Ling Ling Ang | Associate Director |
New York City
Washington, DC Chicago |
+1 212 345 5409
+1 202 466 9259 +312 573 2827 |
lingling.ang@nera.com |
| Dr. Airat Chanyshev | Associate Director | New York City | +1 212 345 7336 | airat.chanyshev@nera.com |
| Erin B. McHugh | Associate Director |
London
New York City |
+44 20 7659 8736
+1 212 345 2990 |
erin.mchugh@nera.com |
| Bryan Ray | Associate Director | White Plains, NY | +1 914 448 4004 | bryan.ray@nera.com |
| Dr. Michael Baye | Affiliated Academic | Washington, DC | +1 202 466 9298 | michael.baye.affiliate@nera.com |
| Mark L. Berenblut | Affiliated Consultant |
Toronto
New York City London |
+1 416 868 7311
+1 917 475 0020 +44 20 3769 1096 |
mark.berenblut.affiliate@nera.com |
| Dr. Sharon Brown-Hruska | Affiliated Consultant | Washington, DC | +1 202 466 3510 | sharon.hruska.affiliate@nera.com |
| Dr. Andrew Carron | Affiliated Consultant |
New York City
London |
+1 212 345 5407
+44 20 7659 8500 |
andrew.carron.affiliate@nera.com |
| Dr. Alan Cox | Affiliated Consultant | San Francisco | +1 415 291 1000 | alan.cox.affiliate@nera.com |
| Dr. James Jordan | Affiliated Consultant | Washington, DC | +1 202 466 9263 | james.jordan.affiliate@nera.com |
| Dr. Thomas McCarthy | Affiliated Consultant | Los Angeles | +1 213 346 3000 | thomas.mccarthy.affiliate@nera.com |
| Todd Morrison | Affiliated Consultant | Washington, DC | +1 202 466 9213 | todd.morrison.affiliate@nera.com |
| Dr. Michael Rosenzweig | Affiliated Consultant | Washington, DC | +1 202 466 9231 | michael.rosenzweig.affiliate@nera.com |
| Title | Type | Author | ||
|---|---|---|---|---|
| Transfer Pricing Solutions for Intragroup Shared Services | White Paper | Dr. Niraja Srinivasan and Nihan Mert-Beydilli | ||
| ‘Coca-Cola’ vs. Section 482: Is It Time to Refresh the Regulatory Guidance? | Published Article | Dr. Harlow Higinbotham and Dr. Niraja Srinivasan | ||
| Snapshot of Recent Trends in Asbestos Litigation 2021 Update | Mary Elizabeth C. Stern and Lucy P. Allen | |||
| Going digital multinationals: Navigating economic and social imperatives in a post-pa... | Published Article | Niraja Srinivasan, et al. | ||
| NERA Experts Contribute Chapter to "The Future of the Profit Split Method" | Book | Dr. Harlow Higginbotham and Dr. Vladimir Starkov | ||
| Trends in Canadian Securities Class Actions: 2020 Update | Report | Bradley A. Heys, Robert Patton, and Jielei Mao | ||
| Transfer Pricing Roundtable in Financier Worldwide. | Expert QA | Dr. Vladimir Starkov and Philip de Homont | ||
| Amount B: Facts and Circumstances Matter—Even for Routine Distributors | Published Article | Dr. Harlow Higinbotham, Dr. Niraja Srinivasan, Dr. Vladimir Starkov, and Nihan Mert-Beydilli | ||
| Recent Trends in Securities Class Action Litigation: 2020 Full-Year Review | Report | Janeen McIntosh and Svetlana Starykh | ||
| NERA Experts Comment on the OECD Proposal on Pillar One Blueprint | Brief | Dr. Harlow Higinbotham, Dr. Vladimir Starkov, Dr. Niraja Srinivasan, Nihan Mert Beydilli, Ralph Meghames, and Dr. Emmanuel Llinares | ||